David Leslie Szekeres, EVP, Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 1,250 shares at $18.09 ($23K) on 2021-01-14, disclosed to the SEC on 2021-01-15.
Scheduled sale ($23k) by EVP, Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.16 | 423 | $8K | 33.9% |
| 2 | $18.09 | 827 | $15K | 66.1% |
| Total | $18.11 avg | 1,250 | $23K | 100% |